Karlawish discusses diagnostic tests for Alzheimer’s disease in New York Times article

Jason Karlawish, MD

Jason Karlawish, MD,  leader of the IMPACT Collaboratory  Regulatory and Ethics Core, was  quoted in a December 20th New York Times article, “Alzheimer’s Tests Soon May Be Common. Should You Get One? Diagnostic tests for Alzheimer’s disease are already here. But the results may raise as many questions as they answer.”

Read the article here.